Novo Nordisk A/S
Explore Novo Nordisk A/S
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Novo Nordisk A/S
Explore Novo Nordisk A/S
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$42.7B
▲ 27.8% vs FY2023 ($33.4B)
Net Income: $14.3B
Source: Annual report / company filing
Novo Nordisk A/S reported $42.7B in revenue for fiscal year 2024. This represents a growth of 27.8% compared to the 2023 figure of $33.4B.
FY2024 revenue climbed 27.8% to $42.7 billion, with the semaglutide franchise alone generating roughly three-quarters of sales amid record capacity investment.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.